UREA
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- UREA
- Generic name
- UREA
- Manufacturer
- Bantry Pharma, LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- cb6ddbfc-ea6a-0ddc-e053-2995a90aedc4
- SPL ID
- 36c18d8c-6e56-ad83-e063-6294a90a25fc
- Version
- 3
- Effective date
- 2025-06-04
- Source export date
- 2026-09-28
- Source partition
- 8
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:54:10
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | UREA | openfda.brand_name | |
| generic name | UREA | openfda.generic_name | |
| manufacturer name | Bantry Pharma, LLC | openfda.manufacturer_name | |
| ndc | package | 81542-201-08 | openfda.package_ndc |
| ndc | product | 81542-201 | openfda.product_ndc |
| ndc11 | package | 81542020108 | derived:openfda.package_ndc |
| rxcui | 351155 | openfda.rxcui | |
| spl id | 36c18d8c-6e56-ad83-e063-6294a90a25fc | id | |
| spl set id | cb6ddbfc-ea6a-0ddc-e053-2995a90aedc4 | set_id | |
| unii | 8W8T17847W | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS: KEEP OUT OF REACH OF CHILDREN.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS: Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.